
Dexcom Inc
NASDAQ:DXCM

Intrinsic Value
The intrinsic value of one
DXCM
stock under the Base Case scenario is
50.9
USD.
Compared to the current market price of 81.99 USD,
Dexcom Inc
is
Overvalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Dexcom Inc
Fundamental Analysis

Dexcom’s dominant position in continuous glucose monitoring faces mounting pressure from Abbott’s Freestyle Libre, which offers lower-cost options and wider distribution, potentially diluting Dexcom’s market share and pricing power.
Dexcom’s recognized best-in-class accuracy and brand loyalty in Type 1 diabetes management could preserve its premium pricing and reinforce market leadership despite competitive threats.

Revenue & Expenses Breakdown
Dexcom Inc
Balance Sheet Decomposition
Dexcom Inc
Current Assets | 4.6B |
Cash & Short-Term Investments | 2.7B |
Receivables | 1.2B |
Other Current Assets | 682.5m |
Non-Current Assets | 2.2B |
PP&E | 1.4B |
Intangibles | 118.3m |
Other Non-Current Assets | 655.8m |
Free Cash Flow Analysis
Dexcom Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Dexcom Inc
Revenue
|
4.1B
USD
|
Cost of Revenue
|
-1.6B
USD
|
Gross Profit
|
2.5B
USD
|
Operating Expenses
|
-1.9B
USD
|
Operating Income
|
632.6m
USD
|
Other Expenses
|
-97.4m
USD
|
Net Income
|
535.2m
USD
|
DXCM Profitability Score
Profitability Due Diligence
Dexcom Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Score
Dexcom Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
DXCM Solvency Score
Solvency Due Diligence
Dexcom Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Score
Dexcom Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DXCM Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for
DXCM
is 101.72 USD
with a low forecast of 82.82 USD and a high forecast of 120.75 USD.
Dividends
Current shareholder yield for DXCM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DXCM
stock under the Base Case scenario is
50.9
USD.
Compared to the current market price of 81.99 USD,
Dexcom Inc
is
Overvalued by 38%.